Helmholtz Munich

Helmholtz Munich

Fabian Theis erhält Leibniz-Preis 2023

Die Deutsche Forschungsgemeinschaft (DFG) hat Fabian Theis mit dem Gottfried Wilhelm Leibniz-Preis ausgezeichnet – dem renommiertesten Forschungspreis in Deutschland. Fabian Theis ist Leiter des Computational Health Centers bei Helmholtz Munich und Inhaber des Lehrstuhls für Mathematische Modellierung biologischer Systeme an der Technischen Universität München (TUM). Der Preis ist mit 2,5 Millionen Euro dotiert.

Helmholtz Munich

Fabian Theis wins Leibniz Prize 2023

The German Research Foundation (DFG, Deutsche Forschungsgemeinschaft) awarded Fabian Theis the Gottfried Wilhelm Leibniz Prize – the most prestigious research award in Germany. Fabian Theis is Head of the Computational Health Center at Helmholtz Munich and chair for Mathematical Modelling of Biological Systems at the Technical University of Munich (TUM). The prize is endowed with 2.5 million Euros.

Pint of Science Deutschland

(Bio-) Hacking your body

Join us in learning how researchers are discovering new ways to fight diseases, from fasting to stem cells!

Helmholtz Munich

Interview with Daniel Krappmann, Head of the Research Unit "Signaling and Translation" (SAT)

Helmholtz Munich

Mechanisms of stress hormones: ERC Consolidator Grant goes to Nina Henriette Uhlenhaut

The pandemic, war, or climate change are stressful for many people. In response to stress, the body’s own hormones glucocorticoids are released. High stress hormone levels are associated with metabolic disease and aging, whereas dieting might increase hormone levels but extend lifespan. What are the molecular and physiological effects of elevated hormone levels, and are diets beneficial? Helmholtz Munich researcher Nina Henriette Uhlenhaut has received a European Research Council (ERC) Consolida

Helmholtz Munich

Research Against Cancer and Diabetes: Matthias Hebrok Receives Bavarian Distinguished Professorship

The biologist and medical researcher Matthias Hebrok was awarded the Bavarian Distinguished Professorship. Since 2022 Prof. Hebrok is Director at the Institute for Diabetes and Organoid Technology (IDOT)) at Helmholtz Munich. The Bavarian Ministry of Science is now supporting his scientific work as Professor for Applied Stem Cell and Organoid Systems at the Technical University of Munich (TUM) with the Distinguished Professorship. The Distinguished Professorship Program is part of the “High-Tech

Helmholtz Munich

AI Transforms Blood Disease Diagnosis

In the future, blood samples from patients can be evaluated not only by specialists, but also by artificial intelligence.

LinkedIn

This link will take you to a page that’s not on LinkedIn